Total trials
143
Active
48
Phase 3
0
Total enrollment
106,342
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Naltrexone Hydrochloride | — | — | — | — | — | 1 |
Next readouts
- 2027-04
Top conditions
- Depression6
- Cardiovascular Diseases5
- Obesity5
- Postprandial Hyperglycemia5
- Satiety5
- Healthy4
- Lung Diseases4
- Heart Diseases3
Frequently asked questions about San Diego State University
- How many clinical trials does San Diego State University have on ClinicalTrials.gov?
- San Diego State University is listed as the lead sponsor on 143 clinical trials in ClinicalTrials.gov, 48 of which are currently active (recruiting, enrolling, or ongoing).
- How many of San Diego State University's trials are in Phase 3?
- 0 of San Diego State University's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does San Diego State University focus on?
- San Diego State University's most-studied conditions on ClinicalTrials.gov are Depression, Cardiovascular Diseases, Obesity, Postprandial Hyperglycemia, Satiety.
- When are San Diego State University's next clinical trial readouts?
- San Diego State University has 1 upcoming primary-completion readout tracked here; the soonest is “Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences”, expected around 2027-04.